RxDoctor Payments DataLook up a doctor →

David Larsen, MD

Family Medicine · Salt Lake City, UTNPI 1679548564

Payments from drug & device makers

$1,243,743in general payments, 2019–2025

Across 776 payments — averaging $1602.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$571K
  • Biohaven Pharmaceutical Holding Company Ltd.$280K
  • American Regent$170K
  • H. Lundbeck A S$113K
  • GRT US Holding, Inc.$76K
  • Biohaven Pharmaceuticals, Inc.$26K
  • plus $9K from 54 others
$76,563in research payments, 2019–2025

Across 28 payments — averaging $2734.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$77K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer190$570,862
Biohaven Pharmaceutical Holding Company Ltd.90$279,865
American Regent1$169,651
H. Lundbeck A S52$113,023
GRT US Holding, Inc.22$75,795
Biohaven Pharmaceuticals, Inc.12$25,852
Eli Lilly2$1,840
AbbVie(2 entities)43$770
Lilly USA, LLC36$586
Boehringer Ingelheim23$464
Johnson & Johnson(2 entities)26$442
Amgen(2 entities)27$436
Novo Nordisk29$412
AstraZeneca(2 entities)27$377
Sanofi-aventis U.S. LLC24$350
GSK20$304
UCB, Inc.10$246
Idorsia Pharmaceuticals US Inc18$217
E.r. Squibb & Sons, L.L.C.13$209
Viiv Healthcare Company9$182
Gilead8$150
Abbott7$149
Dynavax Technologies Corporation9$148
Takeda Pharmaceuticals U.S.A., Inc.8$136
Antares Pharma, Inc.7$115
Merck7$113
Novartis5$102
Exact Sciences6$101
Corcept Therapeutics3$68
Edwards Lifesciences2$50
Medtronic(2 entities)3$49
Lundbeck LLC2$46
Grifols USA, LLC2$45
Xeris Pharmaceuticals, Inc.2$42
Dexcom, Inc.2$40
Neurocrine Biosciences, Inc.2$33
Strongbridge US Inc.2$31
Currax Pharmaceuticals LLC2$30
Boston Scientific1$29
Otsuka America Pharmaceutical, Inc.1$28
Tactile Systems Technology Inc2$27
Hologic Sales And Service, LLC1$24
Ultragenyx Pharmaceutical Inc.1$23
Octapharma USA, Inc.1$23
Inspire Medical Systems, Inc.1$23
Sandoz1$22
Apria Healthcare LLC1$20
Axsome Therapeutics, Inc.1$20
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$19
Neurelis, Inc.1$17
Kowa Pharmaceuticals America, Inc.1$16
Vertex1$16
Endo Pharmaceuticals Inc.1$15
Organon1$14
Supernus Pharmaceuticals, Inc.1$14
Bayer1$14
Teva Pharmaceuticals USA, Inc.1$13
Lucid Diagnostics Inc.1$12
Ironshore Pharmaceuticals Inc.1$12
Eisai Inc.1$12

How this compares

$1,243,743 in reported general payments places this provider in the 95th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah →

Medicare billing

Part B allowed, 2024
$63,485
Medicare patients
178
Services billed
990

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Salt Lake City

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →